Friday, October 16, 2026
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
News articleIEEE Spectrum

Video Friday: Humanoid Robots Celebrate Spring

View original at spectrum.ieee.org
IEEE Spectrum - Technical Title: Video Friday: Humanoid Robots Celebrate Spring Date: 2026-02-20 18:00 Source: https://spectrum.ieee.org/robot-martial-arts <img src="https://spectrum.ieee.org/media-library/five-humanoid-robots-in-red-vests-perform-synchronized-movements-on-a-shiny-stage.png?id=64966934&width=1200&heigh…
Opening lines of the source · IEEE Spectrum · short snapshot — read the full document at the original

What we drew from this source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • Human-robot-AI teams will revolutionize the future of society, the economy, and technology

    80% confidence
  • We now have demonstrations of humanoid walking in a variety of challenging environments

    80% confidence
  • The convergence of technologies including foundation AI models, sensors, actuators, and connectivity is transforming interactions in the physical and digital world

    80% confidence
  • Mars Global Localization algorithm can pinpoint Perseverance's position to within about 10 inches (25 centimeters) in a few minutes

    80% confidence
  • Multiple companies are beginning large-scale deployments of humanoid robots

    80% confidence
  • For intelligent robots to become ubiquitous, we need to solve locomotion, navigation and manipulation at sufficient reliability in widely varying environments

    80% confidence
  • Humanoid robots are nearing peak human performance

    80% confidence
  • Peak robot performance is very far from peak human performance and has yet to be effectively exploited because it requires more than just copying humans

    80% confidence
  • Billions of dollars of funding are pouring into robotics making general-purpose humanoid robots seem closer than ever

    80% confidence

Cited in these Via News reports

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Q4 2026 Biopharma Catalyst Cluster: Late-Stage Readouts and Regulatory Milestones
October 2026 brings a dense run of Phase 3 wins (ALOFT-IPF, RESTORE-3), new data presentations (Roche, Bayer, Lilly, Vertex, Galderma) and regulatory steps (FDA acceptance of Roche's vamikibart BLA, Scholar Rock's EMA resubmission). The next big catalyst is the ivonescimab FDA PDUFA date on 2026-11-14. Obesity combination studies (REDEFINE 4, TOGETHER-PsO) and the 2027 Maritime-1 completion point to more catalysts ahead. QAIAx's speculative AI-linked trial claims (the QIII pilot, targeted for 2027) are an unrelated micro-cap sideshow with weak evidence, and have little in common with the large-cap pipeline news.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,986
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,986 facts checked against source5,378 source documents archived
Query this data → isubstrate.com